Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Belgium's Argenx Advances On More Positive Efgartigimod Data
Filing Imminent For Promising Myasthenia Gravis Therapy
Positive data keeps piling up for efgartigimod • Source: Shutterstock
More from Rare Diseases
More from Scrip